Lannett To Launch Generic Concerta(R), AB-rated Methylphenidate Hydrochloride ER Tablets

PHILADELPHIA, April 30, 2019 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it expects to launch later this quarter Methylphenidate Hydrochloride Extended Release (ER) tablets USP (CII) in 18 mg, 27 mg,... Biopharmaceuticals, Generics, Product Launch Lannett, Concerta , Methylphenidate
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news